Morgan Petronelli is an associate editor for 

and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

She enjoys working out, listening to music, and playing with her dog Scout. You can reach her at 

and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

Videos

Jennifer Powers, MD, associate professor of dermatology at the University of Iowa, talks her recent research investigating how diet and supplements affect patients with mild psoriasis.

Diet and Supplements for Psoriasis?

In this video interview, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

Understanding Type 2 Inflammation

Jason Emer, MD, in this video interview, discusses plasma pen cosmetic treatments, the influx of patient interest, dangers of non-FDA cleared pens, and how to work with SOC patients. 

Plasma Pen Treatments with Jason Emer, MD

In this exclusive video interview, David Prokupek, CEO, Ideal Image, sits down with Dermatology Times to discuss the company's new affiliate program aimed at expanding its national point of care network. 

Ideal Image CEO Discusses New Affiliate Program

Roy Geronemus, MD, clinical professor of dermatology at New York University Medical Center & Dermatology Times editorial advisory board member, discusses the recent FDA clearance of ellacor Micro-Coring Technology for treatment of moderate to severe wrinkles in the mid to lower face.

FDA Clears ellacor Micro-Coring Technology for Wrinkles

 and joined the MJH Life Sciences team in September 2019. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and trying new restaurants. You can reach her at 

Shino Bay Aguilera, DO, reflects on his keynote address highlighting diversity and wellness in aesthetic medicine at Aesthetics Biomedical’s “Perspectives: The Evolution of Aesthetics” symposium.  

Diversity and Wellness with Shino Bay Aguilera, DO

Mark Lebwohl, MD, explains the recent delay in approval of JAK inhibitors by the FDA, how it is affecting the inflammatory skin disease community, and if physicians should be concerned.

FDA Delays Impacting Inflammatory Skin Disease Community

In this video interview, Jerry Bagel, MD, MS, discusses improvement in quality of life for pediatric psoriasis patients and current and emerging treatments. 

Utilizing the Psoriasis Toolbox 

In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again. 

Valisure CEO Shares Thoughts on Johnson & Johnson Sunscreen Recall

Joshua Zeichner, MD, associate professor of dermatology and director of cosmetic & clinical research in dermatology, Mount Sinai Hospital, New York, discusses the impact of the recent FDA approval of Twyneo (Sol-Gel) for the treatment of acne.

Expert Interviews